Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus

NCT02548650 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction
Diabetes Mellitus
Peripheral Arterial Disease

Interventions

DRUG: Vorapaxar
DRUG: Clopidogrel
DRUG: Aspirin

Sponsor

University of Florida

Collaborators

[object Object]